Jiangsu Jiexin Medical Devices Co., Ltd. was established in 2008 with a registered capital of RMB 10 million. 

Headquartered in Shangyuan Village, Hongqiao Town, Taixing City, Jiangsu Province, the company specializes in the research, development, production, and sales of various models of high-pressure angiographic injectors(CT/MRI/DSA), high-pressure connecting tubes(CT/MRI/DSA).

It is a high-tech enterprise integrating R&D, manufacturing, and marketing.

The company operates strictly in accordance with GMP (Good Manufacturing Practice) standards and has obtained ISO9001 and ISO13485 quality management system certifications, CE certification, and registration with the National Medical Products Administration of China. We operate 15,000 square meters of modern manufacturing facilities, including 4,000 square meters of Class 100,000 and Class 10,000 cleanrooms that meet GMP standards, equipped with advanced automated injection molding machines, a fully automated ethylene oxide sterilization system, and a biological laboratory, ensuring the stability and safety of product quality.

All raw materials are sourced from world-class medical suppliers in Europe and the United States, ensuring that our products meet international quality standards. With the competitive advantages of higher quality and better pricing, our products are widely used in top hospitals across China, including Fuwai Hospital of the Chinese Academy of Medical Sciences, Beijing Anzhen Hospital, TEDA International Cardiovascular Hospital in Tianjin, Wuhan Asia Heart Hospital, Guangdong Provincial People’s Hospital, and West China Hospital of Sichuan University. Our products are also exported to dozens of countries and regions such as France, Germany, Japan, South Korea, Singapore, Russia, Italy, and South Africa.

Jiexin actively participates in domestic and international medical industry exchanges, maintaining close cooperation with professional organizations such as the Chinese Medical Association